| Literature DB >> 32864153 |
Salwa Massad1, Mehari Gebre-Medhin2, Omar Dary3, Marwah Abdalla4, Steve Holleran5, Wahida Karmally6, Paula Bordelois7, Umaiyeh Khammash1, Richard J Deckelbaum5,8.
Abstract
BACKGROUND: In 1996 and in 2006, Palestine initiated salt iodization and multiple micronutrient fortification of wheat flour, respectively as a strategy to prevent deficiencies of these nutrients. In 2009, we assessed the impact of these interventions on the health and nutritional status of schoolchildren residing in the West Bank.Entities:
Keywords: Anemia; Children; Fortification; Micronutrient; Palestine
Year: 2020 PMID: 32864153 PMCID: PMC7448451 DOI: 10.1186/s40795-020-00367-2
Source DB: PubMed Journal: BMC Nutr ISSN: 2055-0928
Palestinian Flour Fortification Formula (Palestinian National Authority, Ministry of Health, Primary Health Care & Public Health Directorate, 2015)
| Average addition level | Minimum-maximum levela | |
|---|---|---|
| Iron (ferrous sulfate) (mg/kg) | 34.4 | 25.0–60.0 |
| Zinc (zinc oxide) (mg/kg) | 20.6 | 15.0–40.0 |
| Folic acid (mg/kg) | 1.5 | 1.0–2.5 |
| Vitamin B12 (μg/kg) | 4.0 | min. 2.5 |
| Thiamine (mononitrate) (mg/kg) | 2.9 | min. 2.0 |
| Riboflavin (mg/kg) | 3.6 | min. 2.5 |
| Vitamin B6 (pyridoxine) (mg/kg) | 3.6 | min. 2.5 |
| Niacin (niacinamide) (mg/kg) | 35.0 | min. 25.0 |
| Vitamin A (palmitate, CWS-250) (mg/kg)b | 1.5 | 1.00–2.5 |
| Vitamin D3 (100 CWS/A) (mg/kg)b | 0.023 | 0.015–0.050 |
aMinimum and safe maximum levels of fortification
bCWS cold water soluble, CWS/A cold water soluble, coated w. gum Arabic
Fig. 1Prevalence of low micronutrient levels in the study population
Micronutrient status of the study sample by gender and grade level, (N = 1484), 2009
| % with Deficiency | |||||||
|---|---|---|---|---|---|---|---|
| First Grade | Sixth Grade | Ninth Grade | Total | ||||
| Mean age (SD) in years | |||||||
| 31.3 | 16.9 | 17.1 | 16.2 | 14.9 | 13.5 | 18.8 | |
| - (< 3.1 μg/L) | 0 | 0 | 0 | 0.4 | 0 | 0.4 | 0.1 |
| - (< 7.0 μg/L) | 0.4 | 2.4 | 1.2 | 1.6 | 3.8 | 4.9 | 2.4 |
| - (> 20 μg/L) | 29.3 | 33.3 | 22.4 | 32.7 | 18.2 | 15.5 | 25.2 |
| 34.7 | 35.7 | 32.2 | 33.6 | 20.0 | 31.0 | 31.3 | |
| - Marginal3 | 26.8 | 37.3 | 41.6 | 37.1 | 46.6 | 39.2 | 40.0 |
| - Deficient4 | 15.9 | 13.5 | 21.2 | 27.8 | 36.0 | 19.2 | 22.0 |
| - Tri-iodothyroxine5 | 0 | 0 | 0 | 0.8 | 0.4 | 0 | 0.2 |
| - Thyroxine hormone6 | 3.7 | 2.8 | 6.1 | 10.9 | 14.4 | 12.2 | 8.2 |
| - Thyroid- stimulation hormone7 | 6.1 | 4.0 | 2.9 | 5.2 | 1.3 | 2.5 | 3.6 |
aMCV<75 fL, 2Zinc < 65 μg/dL, 3B12< 300 pg/mL ,4B12<221 pg/ml, 5FT3 < 2.3 pg/mL, 6FT4 < 0.89 g/dL. 7TSH> 5.5 uIU/mL
Fig. 2Prevalence of Anemia, Iron deficiency, and Iron Deficiency Anemia by District and Gender, *Note: F: Female, M: Male, ID = iron deficiency, IDA = iron deficiency anemia